Quick Takeaways
- ACORN BIOVENTURES, L.P. filed SCHEDULE 13G/A for Mural Oncology plc Common Stock, $0.01 par value per share (MURA).
- Disclosed ownership: 6.3%.
- Date of event: 09 Aug 2024.
ACORN BIOVENTURES, L.P. - 09 Aug 2024 SCHEDULE 13G/A Report for Mural Oncology plc Common Stock, $0.01 par value per share (MURA)
- Filing Manager
- ACORN BIOVENTURES, L.P.
- Reporting Manager
- Anders Hove
- Symbol
- MURA
- Shares outstanding
- 17,098,762 shares
- Disclosed Ownership
- 1,077,222 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2024, 12:00:55 UTC
- Date of event
- 09 Aug 2024
- Next filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ACORN BIOVENTURES, L.P. disclosed 6.3% ownership in Mural Oncology plc Common Stock, $0.01 par value per share (MURA) on 09 Aug 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2024, 12:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. | 2.7% | 452,433 | 0 | 452,433 | Anders Hove | Manager | |
| ACORN BIOVENTURES 2, L.P. | 3.7% | 624,789 | 0 | 624,789 | Anders Hove | Manager | |
| ACORN CAPITAL ADVISORS GP, LLC | 2.7% | 452,433 | 0 | 452,433 | Anders Hove | Manager | |
| ACORN CAPITAL ADVISORS GP 2, LLC | 3.7% | 624,789 | 0 | 624,789 | Anders Hove | Manager | |
| Anders Hove | 6.3% | 1,077,222 | 0 | 1,077,222 | Anders Hove | Manager |